Startup Fundraising in India: Pre-Seed to Series A

Raising capital in India has never been more accessible — or more misunderstood. Every week I sit across the table from founders who have built genuinely good products but walk into fundraising conversations with the wrong instrument, the wrong valuation expectation, and zero awareness of the tax landmines waiting on the other side. This article is the brief I wish I could hand every founder before they send their first cold email to an investor.

The Indian Fundraising Landscape Today

India's startup ecosystem is now the third-largest in the world by number of unicorns, and the capital stack available to founders has widened considerably. At the earliest stages you are typically looking at angel investors — high-net-worth individuals who write cheques ranging from INR 5 lakh to INR 2 crore. Many operate through angel networks like Mumbai Angels, Indian Angel Network, or LetsVenture, which pool capital and share deal flow.

Beyond angels, micro-VCs and seed-stage venture capital funds have proliferated. Firms like Titan Capital, Better Capital, and 100X.VC now occupy the INR 25 lakh to INR 5 crore range. For Series A and beyond, institutional VCs — Sequoia Capital India (now Peak XV), Accel, Elevation Capital, Matrix Partners — deploy INR 10 crore to INR 100 crore. Family offices are an increasingly important and often underrated source of capital, particularly for B2B startups that may not fit the hypergrowth VC thesis but have strong unit economics.

Instruments: SAFE Notes vs CCDs vs Priced Equity Rounds

Choosing the right instrument is one of the most consequential decisions founders make — and one of the most frequently botched. Here is when each instrument makes sense:

SAFE notes (Simple Agreement for Future Equity) work well at pre-seed and seed when you want speed and simplicity. A SAFE is not debt — it is a contractual right to future equity. There is no interest rate, no maturity date, and no board seat. YC's standard post-money SAFE is widely accepted in India, but founders must understand the post-money mechanics: every SAFE issued dilutes the founders, not future investors. Indian law treats SAFEs as “other securities,” and you need to ensure compliance with the Companies Act provisions on allotment and with FEMA pricing guidelines if the investor is a non-resident.

Compulsorily Convertible Debentures (CCDs) are the instrument of choice when you need regulatory certainty. CCDs are explicitly recognized under the Companies Act, 2013 and by RBI under FEMA for FDI purposes. They convert into equity at a pre-agreed trigger — typically the next priced round or a longstop date. The conversion ratio can embed a valuation cap or discount, mimicking SAFE economics while sitting on stronger legal ground for cross-border transactions.

Priced equity rounds — issuing shares at a fixed per-share price — become the right choice once you have enough traction to justify a formal valuation. This is typically Series A and beyond. A priced round involves a shareholders' agreement (SHA), a share subscription agreement (SSA), and often a full valuation report from a registered valuer. It is slower and more expensive, but it gives everyone clean legal certainty and sets a definitive cap table.

Valuation Methodologies for Early-Stage Startups

Valuation at pre-seed and seed is more art than science, and founders need to accept that. Discounted Cash Flow (DCF) is nearly useless for a company with 6 months of revenue history and a negative EBITDA — the terminal value assumptions dominate the output and the sensitivity range is so wide that the number is functionally meaningless.

What actually works at early stages: comparable transactions — look at what similar companies in your sector and stage raised at, and triangulate. Revenue multiples are useful if you have revenue; typically Indian SaaS companies at seed trade at 15x-30x ARR, while D2C and marketplace businesses trade at 3x-8x GMV or revenue depending on margin profile. The Berkus Method and Scorecard Method can frame pre-revenue conversations. For regulatory purposes — particularly Section 56(2)(viib) — you will need a registered valuer to issue a report using one of the prescribed methods under Rule 11UA: DCF or NAV. The practical trick is to build a defensible DCF that arrives at a number consistent with what the market is actually willing to pay. Your CA should be the one reconciling these two realities.

The Angel Tax Trap: Section 56(2)(viib)

Section 56(2)(viib) of the Income Tax Act is the provision that has kept more founders up at night than any cap table dispute. In plain language: if a closely held company issues shares at a premium that exceeds the “fair market value” as determined by a prescribed method, the excess premium is taxed as income in the hands of the company. The tax rate? Your applicable slab — which for a company means 25% or 30% plus surcharge and cess.

The problem is obvious. Startups routinely raise at valuations that far exceed any reasonable DCF or NAV computation because investors are pricing in optionality, TAM, and team — things that do not show up in a valuation report. This means the company can receive a notice demanding tax on the “excess” premium.

DPIIT recognition is the primary defence. Startups recognized by the Department for Promotion of Industry and Internal Trade and certified by the Inter-Ministerial Board are exempt from Section 56(2)(viib) on investments from resident investors. The 2023 amendments also exempted investments from non-residents, resolving a long-standing pain point. However, DPIIT recognition has eligibility criteria — the entity must be less than 10 years old, turnover must not exceed INR 100 crore in any financial year, and the entity must be working towards innovation or improvement of products, processes, or services. Filing for DPIIT recognition should be one of the first things a startup founder does, ideally before the first external round.

Legal Structure: What Investors Look for in the Cap Table

Investors — especially institutional ones — are allergic to messy cap tables. Here is what a clean structure looks like from the investor's perspective: founders hold a clear majority (70%+ at pre-seed, 55%+ at seed), there is an ESOP pool of 10-15% reserved and board-approved, prior investors hold equity or instruments that convert cleanly, and there are no dormant shareholders, undocumented verbal promises, or shares issued to friends and family at arbitrary valuations.

The entity should be a private limited company — not an LLP, not a partnership, not a proprietorship. If you started as an LLP, convert before you fundraise. Investors also look at the authorized share capital (is it high enough to accommodate the round?), existing charges or encumbrances on the company, and whether all prior allotments have been properly filed with the Registrar of Companies. ROC compliance is non-negotiable: your annual returns, financial statements, and board resolutions must be current.

Term Sheet Negotiation Essentials

A term sheet is a non-binding document that outlines the key economic and governance terms of an investment. Founders who negotiate without understanding the following three provisions almost always regret it:

Liquidation preference determines who gets paid first in an exit. A 1x non-participating liquidation preference is market standard — the investor gets back their invested amount before common shareholders, or converts to common and participates pro-rata, whichever is higher. Watch out for participating preferred (double-dip) structures where the investor gets their money back and then also participates in the remaining proceeds — these are aggressively investor-friendly and should be pushed back on at early stages.

Anti-dilution protection shields investors if a future round happens at a lower valuation (a “down round”). Broad-based weighted average anti-dilution is the founder-friendly standard. Full ratchet — where the investor's conversion price resets entirely to the lower price — is punitive and should be resisted unless you are in a deeply distressed negotiation.

Board seats and protective provisions give investors governance control. At seed, most investors do not demand a board seat but will ask for observer rights and certain veto powers (called protective provisions or affirmative vote matters) — typically over new share issuances, debt above a threshold, related party transactions, and changes to the articles of association. Understand exactly what you are giving up and negotiate sunset clauses where possible.

Due Diligence: The CA's Checklist

When an investor decides to move forward, their legal and financial teams will run due diligence on your company. As a CA who has been on both sides of this table, here is what I tell founders to have ready before the process begins:

Financial diligence: audited financial statements for all completed years, management accounts for the current year (monthly P&L, balance sheet, cash flow), bank statements for 12-24 months, revenue recognition policies documented clearly, and a detailed cap table with all instruments outstanding.

Tax diligence: income tax returns and computation for all years, GST returns and reconciliation (GSTR-1 vs GSTR-3B vs books), TDS compliance certificates, any pending assessments or notices, and transfer pricing documentation if applicable.

Legal and corporate diligence: certificate of incorporation, MOA and AOA (current versions), all board and shareholder resolutions, ROC filings (annual returns and financial statements), material contracts (customer, vendor, employment), IP assignments from founders and employees, and ESOP plan documents with grant letters.

Common Mistakes Founders Make

After advising dozens of fundraising transactions, I see the same mistakes on repeat:

Overvaluation at seed. Raising at an inflated valuation feels good in the short term but creates a trap — if you cannot grow into that valuation before your next round, you face a down round, triggering anti-dilution provisions and signalling weakness to the market. Price your round at a level you are confident you can 3-5x within 18 months.

Messy books. Investors will walk away from a deal if the books are unreliable. Unreconciled bank statements, revenue booked on cash basis instead of accrual, personal expenses running through the company — these are not just red flags, they are deal-killers. Get your books cleaned up before you start pitching, not after a term sheet lands.

Wrong instrument for the stage. Using a priced round when you should be using a SAFE burns time and legal fees. Using a SAFE when FEMA requires a CCD for a foreign investor creates regulatory risk. Match the instrument to the stage, the investor profile, and the regulatory context.

Ignoring Section 56(2)(viib). Too many founders raise capital without DPIIT recognition and then discover the angel tax liability months later during assessment. By then, the exemption window may have closed. This is preventable.

Why Your CA Matters More Than You Think

Fundraising is not just a legal exercise — it is a financial structuring exercise. Your lawyer drafts the documents, but your CA should be the one modelling the dilution impact, running the valuation, ensuring Section 56 compliance, advising on the optimal instrument, reviewing the cap table for consistency, and pressure-testing the term sheet economics. A CA who understands capital markets — not just tax compliance — is the difference between a clean round and a round that creates problems for the next three years.

At DRSPV & Associates, fundraising advisory is one of our core practice areas. We work with founders from financial model to signed SHA — handling valuation reports, DPIIT filings, regulatory compliance, and investor-side diligence coordination. If you are preparing to raise and want to get the financial foundation right before you walk into investor meetings, that is exactly the kind of engagement I take on personally.

Book a consultation — let us make sure your fundraise is built on clean numbers, the right instrument, and zero regulatory surprises.